Hospital- Versus Community-based Syringe Exchange: a Randomized Controlled Trial

Overview

Journal AIDS Educ Prev

Specialties Infectious Diseases
Medical Education

Date 2007 Apr 7

PMID 17411413

Citations 8

Authors

Carmen L Masson

James L Sorensen

David C Perlman

Michael S Shopshire

Kevin L Delucchi

TeChieh Chen

Karl Sporer

Don Des Jarlais

Sharon M Hall

Affiliations

Soon will be listed here.

Abstract

This study examined the effect of syringe exchange program setting on the injection practices, health status, and health service utilization patterns of injection drug users (IDUs) recruited from a public urban hospital. One hundred sixty-six participants were randomized to either community- or hospital-based syringe exchange services. Poisson regression models were used to compare service utilization between groups. In both conditions, risky drug use practices decreased, and physical health functioning improved over time. Hospital-based syringe exchange program (SEP) attendees had 83% more inpatient admissions (p < .0001) and 22% more ambulatory care visits (p < .0001) than those assigned to the community-based SEP condition. Syringe exchange services that are integrated into public hospital settings may serve as a valuable strategy to engage hard to reach IDU populations in behavioral interventions designed to reduce HIV risk transmission behaviors and increase access to, or engagement in, the use of secondary and tertiary preventive medical care.

Citing Articles

Perspectives of patients who inject drugs on a needle and syringe program at a large acute care hospital.

Brooks H, Speed K, Dong K, Salvalaggio G, Pauly B, Taylor M PLoS One. 2024; 19(2):e0297584.

PMID: 38359010 PMC: 10868849. DOI: 10.1371/journal.pone.0297584.

Alignment of substance use community benefit prioritization and service lines in US hospitals: a cross-sectional study.

Cronin C, Kubacki L, Donovan L, Puro N, Lavinder D, Schuller K Addict Sci Clin Pract. 2024; 19(1):11.

PMID: 38351004 PMC: 10865679. DOI: 10.1186/s13722-024-00442-0.

Community Coalitions' Perspectives on Engaging with Hospitals in Ohio to Address the Opioid Crisis.

Walker D, Shiu-Yee K, Chen S, DePuccio M, Jackson R, McAlearney A Popul Health Manag. 2022; 25(6):729-737.

PMID: 36315182 PMC: 10024063. DOI: 10.1089/pop.2022.0174.

Syringe Services Programs' Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them.

Broz D, Carnes N, Chapin-Bardales J, Des Jarlais D, Handanagic S, Jones C Am J Prev Med. 2021; 61(5 Suppl 1):S118-S129.

PMID: 34686281 PMC: 11334402. DOI: 10.1016/j.amepre.2021.05.044.

What Strategies Are Hospitals Adopting to Address the Opioid Epidemic? Evidence From a National Sample of Nonprofit Hospitals.

Franz B, Cronin C, Pagan J Public Health Rep. 2020; 136(2):228-238.

PMID: 33176117 PMC: 8093846. DOI: 10.1177/0033354920968805.

References

Bluthenthal R, Kral A, Lorvick J, Watters J . Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Med Anthropol. 1998; 18(1):61-83. DOI: 10.1080/01459740.1997.9966150. View

Vlahov D, Junge B, Brookmeyer R, Cohn S, Riley E, Armenian H . Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 16(5):400-6. DOI: 10.1097/00042560-199712150-00014. View

Hankins C . Syringe exchange in Canada: good but not enough to stem the HIV tide. Subst Use Misuse. 1998; 33(5):1129-46. DOI: 10.3109/10826089809062211. View

Heimer R . Can syringe exchange serve as a conduit to substance abuse treatment?. J Subst Abuse Treat. 1998; 15(3):183-91. DOI: 10.1016/s0740-5472(97)00220-1. View

Davidson A, Bertram S, Lezotte D, Marine W, Rietmeijer C, Hagglund B . Comparison of health status, socioeconomic characteristics, and knowledge and use of HIV-related resources between HIV-infected women and men. Med Care. 1998; 36(12):1676-84. DOI: 10.1097/00005650-199812000-00005. View

Kerr T, Wood E, Grafstein E, Ishida T, Shannon K, Lai C . High rates of primary care and emergency department use among injection drug users in Vancouver. J Public Health (Oxf). 2004; 27(1):62-6. DOI: 10.1093/pubmed/fdh189. View

Molitor F, Kuenneth C, Waltermeyer J, Mendoza M, Aguirre A, Brockmann K . Linking HIV-infected persons of color and injection drug users to HIV medical and other services: the California Bridge Project. AIDS Patient Care STDS. 2005; 19(6):406-12. DOI: 10.1089/apc.2005.19.406. View

Fleishman J, Gebo K, Reilly E, Conviser R, Mathews W, Korthuis P . Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002. Med Care. 2005; 43(9 Suppl):III40-52. DOI: 10.1097/01.mlr.0000175621.65005.c6. View

Laine C, Lin Y, Hauck W, Turner B . Availability of medical care services in drug treatment clinics associated with lower repeated emergency department use. Med Care. 2005; 43(10):985-95. DOI: 10.1097/01.mlr.0000178198.79329.89. View

10.

Rockwell R, Des Jarlais D, Friedman S, Perlis T, Paone D . Geographic proximity, policy and utilization of syringe exchange programmes. AIDS Care. 1999; 11(4):437-42. DOI: 10.1080/09540129947811. View

11.

French M, McGeary K, Chitwood D, McCoy C . Chronic illicit drug use, health services utilization and the cost of medical care. Soc Sci Med. 2000; 50(12):1703-13. DOI: 10.1016/s0277-9536(99)00411-6. View

12.

Riley E, Safaeian M, Strathdee S, Marx M, Huettner S, Beilenson P . Comparing new participants of a mobile versus a pharmacy-based needle exchange program. J Acquir Immune Defic Syndr. 2000; 24(1):57-61. DOI: 10.1097/00126334-200005010-00010. View

13.

Madray H, van Hulst Y . Reducing HIV/AIDS high-risk behavior among injection drug users: peers vs. education. J Drug Educ. 2000; 30(2):205-11. DOI: 10.2190/1DWM-D9WA-22R1-70Q0. View

14.

Hagan H, Thiede H . Changes in injection risk behavior associated with participation in the Seattle needle-exchange program. J Urban Health. 2000; 77(3):369-82. PMC: 3456035. DOI: 10.1007/BF02386747. View

15.

Cunningham W, Markson L, Andersen R, Crystal S, Fleishman J, Golin C . Prevalence and predictors of highly active antiretroviral therapy use in patients with HIV infection in the united states. HCSUS Consortium. HIV Cost and Services Utilization. J Acquir Immune Defic Syndr. 2000; 25(2):115-23. DOI: 10.1097/00042560-200010010-00005. View

16.

Laine C, Hauck W, Gourevitch M, Rothman J, Cohen A, Turner B . Regular outpatient medical and drug abuse care and subsequent hospitalization of persons who use illicit drugs. JAMA. 2001; 285(18):2355-62. DOI: 10.1001/jama.285.18.2355. View

17.

Valente T, Foreman R, Junge B, Vlahov D . Needle-exchange participation, effectiveness, and policy: syringe relay, gender, and the paradox of public health. J Urban Health. 2001; 78(2):340-9. PMC: 3456352. DOI: 10.1093/jurban/78.2.340. View

18.

Perlman D, Gourevitch M, Trinh C, Salomon N, Horn L, Des Jarlais D . Cost-effectiveness of tuberculosis screening and observed preventive therapy for active drug injectors at a syringe-exchange program. J Urban Health. 2001; 78(3):550-67. PMC: 3455907. DOI: 10.1093/jurban/78.3.550. View

19.

Laufer F . Cost-effectiveness of syringe exchange as an HIV prevention strategy. J Acquir Immune Defic Syndr. 2001; 28(3):273-8. DOI: 10.1097/00042560-200111010-00012. View

20.

. Revised guidelines for HIV counseling, testing, and referral. MMWR Recomm Rep. 2001; 50(RR-19):1-57; quiz CE1-19a1-CE6-19a1. View